Evidence map›Paper›PMID 39008056›Full record

ArticleImmunoHorizons2024

Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations.

Kelsey Voss, Todd Bartkowiak, Allison E Sewell, Channing Chi, Madelyn D Landis, Samuel Schaefer, Heather H Pua, James A Connelly, Jonathan M Irish, Jeffrey C Rathmell and 1 more

Abstract readCase Reports
In one paragraph

Article in ImmunoHorizons, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kelsey VossDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-1732-2682
Todd BartkowiakDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-2396-0197
Allison E SewellDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-7077-0762
Channing ChiDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-4987-4764
Madelyn D LandisDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Samuel SchaeferDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-8175-1791
Heather H PuaDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-9271-2608
James A ConnellyVanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-7223-375X
Jonathan M IrishDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN.ORCID 0000-0001-9428-8866
Jeffrey C RathmellDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-4106-3396
Saara KavianyHuman Immunology Discovery Initiative of the Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Autoimmune Drivers and Protectors Team Science (ADAPTS)U01AI176244 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES, Jeffrey C Rathmell · 2023 to 2026
$5.1M
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory diseaseR01DK105550 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey C Rathmell · 2015 to 2026
$4.7M
Extracellular RNA Communication in Lung InflammationDP2HL152426 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PUA, HEATHER H · 2019 to 2019
$2.5M
MicroRNA-23 Cluster Regulation of Helper T cell Differentiation and FunctionK08AI116949 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PUA, HEATHER H · 2015 to 2019
$828k
NHLBI NIH HHS DP2 HL152426NIAID NIH HHS K08 AI116949NIAID NIH HHS U01 AI176244NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK105550
6 · The paper itself

Abstract

The transcription factor FOXN1 plays an established role in thymic epithelial development to mediate selection of maturing thymocytes. Patients with heterozygous loss-of-function FOXN1 variants are associated with T cell lymphopenia at birth and low TCR excision circles that can ultimately recover. Although CD4+ T cell reconstitution in these patients is not completely understood, a lower proportion of naive T cells in adults has suggested a role for homeostatic proliferation. In this study, we present an immunophenotyping study of fraternal twins with low TCR excision circles at birth. Targeted primary immunodeficiency testing revealed a heterozygous variant of uncertain significance in FOXN1 (c.1205del, p.Pro402Leufs*148). We present the immune phenotypes of these two patients, as well as their father who carries the same FOXN1 variant, to demonstrate an evolving immune environment over time. While FOXN1 haploinsufficiency may contribute to thymic defects and T cell lymphopenia, we characterized the transcriptional activity and DNA binding of the heterozygous FOXN1 variant in 293T cells and found the FOXN1 variant to have different effects across several target genes. These data suggest multiple mechanisms for similar FOXN1 variants pathogenicity that may be mutation specific. Increased understanding of how these variants drive transcriptional regulation to impact immune cell populations will guide the potential need for therapeutics, risk for infection or autoimmunity over time, and help inform clinical decisions for other variants that might arise.

Indexed as

Forkhead Transcription FactorsHeterozygoteImmunophenotypingFemaleHaploinsufficiencyHEK293 CellsHumansInfant, NewbornLymphopeniaMaleMutationThymus GlandT-LymphocytesForkhead Transcription FactorsWhn protein

Identifiers

PMID39008056
PMCPMC11294276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.